Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] Samsung Electronics (005930) – Mirae Asset Securities | Memory ASP Upgrades · Groq LPU Order · Foundry Valuation Discount Narrowing / 2026-03-18 Research
  • [IR] SK hynix (000660 / SKHY) – Q1 2025 Earnings Presentation / 2025-04-24 IR Room
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | LTA · HBM Demand · Valuation Re-rating / 2026-05-27 Research
  • [Research] SK Telecom (017670 / SKM) – Mirae Asset Securities | 2Q26 Earnings Beat Preview · Significant AIDC Capacity Expansion · Top Pick Maintained / 2026-07-15 Research
  • [Research] ABL Bio (298380) – Mirae Asset Securities | BBB Shuttle Re-rating · IGF1R Competitiveness · ABL001 Data Readout / 2026-03-26 Research
  • [Research] Samsung Electronics (005930) – Daishin Securities | Commodity Memory ASP Growth · Full-Year Profit Over KRW 200T · Cash Asset Expansion / 2026-02-23 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Data Center Backlogs · LTA · Earnings Visibility / 2026-05-11 Research
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research

[Research] Samsung Electro-Mechanics (009150) – Daishin Securities | FC-BGA Investment · MLCC Supply Shortage · Valuation Re-rating / 2026-04-22

Posted on 4월 22, 20268월 25, 2026 By ksb220805@gmail.com

Brokerage : Daishin Securities

Analyst : Kang-ho Park, Ji-won Seo (RA)

Investment Rating : BUY (Maintained)

Target Price : KRW 920,000 (Raised)

Core Momentum : Valuation re-rating outlook driven by expanding FC-BGA investments for AI servers and severe MLCC supply tightness leading to product mix enrichment and price increase potential

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: BUY maintained; 6-month Target Price raised by 67.3% to KRW 920,000.
  • Valuation Methodology: Applied a target P/E of 46.5x (historical peak multiple) to 2027F EPS (+18.2% upward revision).
  • 1Q26 Earnings Forecast (Analyst Estimate):
    • Revenue: KRW 3.058 Trillion (+11.7% YoY, +5.4% QoQ, in line with consensus)
    • Operating Profit: KRW 271.0 Billion (+35.3% YoY, +13.3% QoQ, in line with consensus)
    • Net Profit: KRW 228.0 Billion (+70.5% YoY, +2.3% QoQ)
  • 2Q26 Earnings Forecast:
    • Revenue: KRW 3.070 Trillion (+10.2% YoY, +0.4% QoQ)
    • Operating Profit: KRW 386.0 Billion (+81.2% YoY, +42.3% QoQ)
    • Net Profit: KRW 315.0 Billion (+143.1% YoY, +38.3% QoQ)
  • Annual Earnings Forecasts (2026F – 2028F):
    • 2026F: Revenue KRW 12.703 Trillion / Operating Profit KRW 1.534 Trillion (+68% YoY, +8.7% revision) / Controlling Net Profit KRW 1.246 Trillion
    • 2027F: Revenue KRW 13.830 Trillion / Operating Profit KRW 1.936 Trillion (+28.2% YoY, +16.4% revision) / Controlling Net Profit KRW 1.534 Trillion
    • 2028F: Revenue KRW 14.252 Trillion / Operating Profit KRW 1.977 Trillion / Controlling Net Profit KRW 1.570 Trillion
  • Key Financial Multiples (2026F):
    • EPS: KRW 16,051 (+10.2% revision)
    • P/E: 42.4x / P/B: 4.9x
    • ROE: 12.2% / Operating Margin (OPM): 12.1%

🚀 2. [Market Opportunities & Business Outlook]

  • FC-BGA & Package Solution Division:
    • 2026 FC-BGA revenue is projected at KRW 1.7 Trillion (+45.5% YoY).
    • The Package Solution division’s contribution to total company operating profit is expected to rise to 28%, up 13%p YoY.
    • Expanding orders from AI server and ASIC clients are expected to bring facilities to full utilization by 4Q26.
    • If the planned additional investment in Vietnam is finalized in 2Q26, capacity and revenue are projected to reach global No. 1 tier in the AI segment by 2028.
  • MLCC Division:
    • Severe supply tightness is projected as demand and market share expand in AI semiconductors and data center infrastructure.
    • Book-to-Bill (BB) ratio expanded from 1.0 in late 2025 to 1.2–1.3, signaling orders outpacing shipments and fostering favorable conditions for price increases.
    • Capacity utilization remains high at 95–100% in 2026, sustaining levels seen since 2025.
    • Potential price hikes in 2H26 present unmodeled upside to current earnings estimates.
  • Glass Substrate Commercialization:
    • Progressing from R&D and sampling stages into initial prototype mass-production equipment installation.
    • Preemptive investments ahead of Japanese peers are evaluated as a strategic initiative to secure leadership in next-generation packaging.

📝 Editor’s Comment (Perspective)

The analyst views Samsung Electro-Mechanics not merely as a conventional passive component supplier, but as a premier AI hardware platform company advancing toward global market leadership through aggressive capacity additions in high-layer substrates and tightening passive component supply. The underlying analytical perspective places greater strategic significance on reaching full utilization in AI server FC-BGA and MLCC lines, enriching high-margin product mix, and capturing structural pricing power rather than general cyclical set recoveries.

To assess whether this investment thesis continues to materialize, key tracking points include the formal approval of the Vietnam FC-BGA expansion in 2Q26, the sustainability of the MLCC Book-to-Bill ratio (1.2–1.3) and high utilization (95%+), and the realization of broad-based price increases in the second half of the year. These developments can be verified through upcoming quarterly earnings releases, official company IR presentations, periodic regulatory filings (quarterly and annual reports), and DART disclosures.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

글 탐색

Previous Post: [Research] KEPCO (015760 / KEP) – Hanwha Investment & Securities | Energy Price Volatility · Nuclear Baseload Value · Valuation Bottom / 2026-04-21
Next Post: [IR] SK hynix (000660 / SKHY) – Q1 2026 Earnings Presentation / 2026-04-23

Related Posts

  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | 7 Growth Drivers · AI Transformation · Shortage 2026-27 / 2026-01-26 Research
  • [Research] Hanwha Ocean (042660) – Eugene | High-Price Order Mix · Merchant Margin Continuity · Special Ship Pipeline / 2026-07-28 Research
  • [Research] Samsung Biologics (207940) – iM Securities | Spin-off Valuation Re-rating · Biosecure Act Inflows · Plant 6 Groundbreaking / 2026-01-09 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA Seller’s Market · Full Capacity · Multiple Upward / 2026-01-26 Research
  • [Research] Samsung SDI (006400) – DS Investment & Securities | Core Profitability Turnaround · Robust ESS Backlog · Humanoid Physical AI Expansion / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | ADR Listing · HBM Pricing · Valuation Re-rating / 2026-06-30 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | K-Defense Competitiveness · Pipeline Expansion · Rheinmetall JV / 2026-06-17 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | US Operations · Plant 5 Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [IR] SK hynix (000660 / SKHY) – Q2 2024 Earnings Presentation / 2024-07-25 IR Room
  • [Research] Celltrion (068270) – Mirae Asset Securities | New Product Mix Expansion · In-House Cost Efficiency · Valuation vs Peers / 2026-07-28 Research
  • [Research] Alteogen (196170) – Daishin Securities | Validated ALT-B4 Platform · Keytruda SC Milestones Accelerate · Coverage Initiation / 2026-05-19 Research
  • [Research] ABL Bio (298380) – Shinhan Securities | Sanofi Strategy · Clinical Differentiation · Platform Expansion / 2026-02-02 Research
  • [Research] Samsung Electro-Mechanics (009150) – Kyobo Securities | 4Q25 Review · AI Server MLCC · FC-BGA Expansion / 2026-01-26 Research
  • [Research] Samsung Electronics (005930) – Mirae Asset | Mobile DRAM · ASP Upgrades · Shareholder Return / 2026-06-09 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme